INCREASED EXPOSURE TO STATINS IN PATIENTS DEVELOPING CHRONIC MUSCLE DISEASES – (11-24-08)



Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study

While we’re on the topic of well accepted by the public but poorly represented in the literature we need to bring up the statin class of drugs. Despite the fact that every (I’m generalizing here…) primary care doctor in this country feels that “prevention” of heart disease means using a statin drug, the research on its efficacy for primary prevention of CVD is almost nil. As if this wasn’t bad enough, the research on the side effects slowly continues to mount.

This study looks at patients who have been diagnosed with chronic muscle disease (polymyositis, dermatomyositis, etc..) and found that these patients had a much, much higher chance of having had exposure to statins (2.73 times the risk), and this risk went up even higher when these patients also had used proton pump inhibitors for control of stomach acid production.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Drug Research, Heart Disease
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”